At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...